Company intelligence / Profile preview

Deep Intelligent Pharma

Beijing, Beijing, Chinadip-ai.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Deep Intelligent Pharma developed advanced AI-native multi-agent platforms to automate pharmaceutical R&D documentation, translation, medical writing, pharmacovigilance, regulatory affairs support, and knowledge extraction. The company's solutions were widely adopted by over 700 global pharma/biotech/CRO clients before ceasing operations in the mid-to-late Series B stage. No clinical results as it did not run its own drug programs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Notable collaborations with over "700+ pharmas, biotechs, CROs" worldwide; specific major partners are undisclosed.

Beyond the preview

Go deeper on Deep Intelligent Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Intelligent Pharma.

Explore the full profile